Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
5.59
+0.73 (15.02%)
At close: Apr 9, 2025, 4:00 PM
5.55
-0.04 (-0.72%)
Pre-market: Apr 10, 2025, 9:05 AM EDT
Quanterix Employees
Quanterix had 471 employees as of December 31, 2024. The number of employees increased by 30 or 6.80% compared to the previous year.
Employees
471
Change (1Y)
30
Growth (1Y)
6.80%
Revenue / Employee
$291,764
Profits / Employee
-$81,807
Market Cap
216.76M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
QTRX News
- 3 days ago - Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya - Business Wire
- 9 days ago - Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit - Business Wire
- 17 days ago - Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences - Business Wire
- 23 days ago - Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Quanterix Releases Financial Results for the Fourth Quarter of 2024 - Business Wire
- 23 days ago - Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call - Business Wire
- 27 days ago - Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 - Business Wire
- 4 weeks ago - Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences - Business Wire